Cannabinoid Delivery Systems for Pain and Inflammation Treatment
Natascia Bruni | Carlo Della Pepa | Simonetta Oliaro-Bosso | Enrica Pessione | Daniela Gastaldi | Franco Dosio | Della Pepa | Oliaro-Bosso
The release of cannabinoids from a microneedle formulation that is administered transdermally has been reported by Brooke [101], while a patent by Weimann has more recently focused on CBD delivery [102]. Polymeric drug delivery systems are able to protect drugs from degradation and control drug release. Cannabis and Cannabinoids for Chronic Pain. Drugs 2007, 16, 951–965. The endocannabinoid system and pain.
Tags:
- Cannabinoid receptor 2
- Cannabinoid
- Nabiximols
- Cannabinoid receptor 1
- Tetrahydrocannabinol
- Medical cannabis
- Nabilone
- Cannabidiol
- Nanocarrier
- Endocannabinoid system
- Liposome
- Inflammation
- Cannabinoid receptor
- Peripheral neuropathy
- Pharmaceutical formulation
- Topical medication
- Nasal administration
- Anandamide
- Dronabinol
- Pharmacology
- Clinical medicine